Advertisement

Comparison of Clinical Features in Blacks Versus Whites With Hypertrophic Cardiomyopathy

      To date, there has not been a large systematic examination of the hypertrophic cardiomyopathy (HC) phenotype in blacks versus whites. In this study, we investigate differences in presentation of HC between blacks and whites. We included 441 consecutive patients with HC seen at the Johns Hopkins HC clinic in the period from February 2005 to June 2012. We compared 76 blacks for clinical presentation, electrocardiogram, exercise capacity, left ventricular morphology, and hemodynamics by echocardiography to 365 whites. Black patients with HC more often presented with abnormal electrocardiogram (93% vs 80%, p = 0.009), driven by a significant difference in repolarization abnormalities (79% vs 56%, p <0.001). Apical hypertrophy was more common in blacks (26% vs 9%, p <0.001); however, blacks had less severe systolic anterior movement of the mitral valve and had significantly lower left ventricular outflow tract gradients at rest (9 mm Hg; interquartile range [IQR] 7 to 19 vs 16 mm Hg; IQR 8 to 40, p <0.001) and during provocation (36 mm Hg; IQR 16 to 77 vs 59 mm Hg; IQR 26 to 110, p = 0.002). Despite the nonobstructive pathophysiology, blacks had lower exercise capacity (adjusted difference 1.45 metabolic equivalents [0.45 to 2.45], p = 0.005). In conclusion, blacks have an HC phenotype characterized by lower prevalence of the well-recognized echocardiographic features of HC such as systolic anterior movement of the mitral valve and left ventricular outflow tract obstruction and display worse exercise capacity.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Frey N.
        • Luedde M.
        • Katus H.A.
        Mechanisms of disease: hypertrophic cardiomyopathy.
        Nat Rev Cardiol. 2011; 9: 91-100
        • Maron B.J.
        • Carney K.P.
        • Lever H.M.
        • Lewis J.F.
        • Barac I.
        • Casey S.A.
        • Sherrid M.V.
        Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2003; 41: 974-980
        • Movahed M.R.
        • Strootman D.
        • Bates S.
        • Sattur S.
        Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography.
        Cardiovasc Ultrasound. 2010; 8: 54
        • Maron B.J.
        • Gardin J.M.
        • Flack J.M.
        • Gidding S.S.
        • Kurosaki T.T.
        • Bild D.E.
        Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.
        Circulation. 1995; 92: 785-789
        • Goldberg K.C.
        • Hartz A.J.
        • Jacobsen S.J.
        • Krakauer H.
        • Rimm A.A.
        Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients.
        JAMA. 1992; 267: 1473-1477
        • Kizer J.R.
        • Arnett D.K.
        • Bella J.N.
        • Paranicas M.
        • Rao D.C.
        • Province M.A.
        • Oberman A.
        • Kitzman D.W.
        • Hopkins P.N.
        • Liu J.E.
        • Devereux R.B.
        Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.
        Hypertension. 2004; 43: 1182-1188
        • Gersh B.J.
        • Maron B.J.
        • Bonow R.O.
        • Dearani J.A.
        • Fifer M.A.
        • Link M.S.
        • Naidu S.S.
        • Nishimura R.A.
        • Ommen S.R.
        • Rakowski H.
        • Seidman C.E.
        • Towbin J.A.
        • Udelson J.E.
        • Yancy C.W.
        • American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
        • American Association for Thoracic Surgery
        • American Society of Echocardiography
        • American Society of Nuclear Cardiology
        • Heart Failure Society of America
        • Heart Rhythm Society
        • Society for Cardiovascular Angiography and Interventions
        • Society of Thoracic Surgeons
        2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
        Circulation. 2011; 124: 2761-2796
        • Maron B.J.
        • Seidman J.G.
        • Seidman C.E.
        Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2004; 44: 2125-2132
        • Bos J.M.
        • Maron B.J.
        • Ackerman M.J.
        • Haas T.S.
        • Sorajja P.
        • Nishimura R.A.
        • Gersh B.J.
        • Ommen S.R.
        Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
        Am J Cardiol. 2010; 106: 1481-1486
        • James P.A.
        • Oparil S.
        • Carter B.L.
        • Cushman W.C.
        • Dennison-Himmelfarb C.
        • Handler J.
        • Lackland D.T.
        • LeFevre M.L.
        • MacKenzie T.D.
        • Ogedegbe O.
        • Smith Jr., S.C.
        • Svetkey L.P.
        • Taler S.J.
        • Townsend R.R.
        • Wright Jr., J.T.
        • Narva A.S.
        • Ortiz E.
        2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
        JAMA. 2014; 311: 507-520
        • Corrado D.
        • Pelliccia A.
        • Heidbuchel H.
        • Sharma S.
        • Link M.
        • Basso C.
        • Biffi A.
        • Buja G.
        • Delise P.
        • Gussac I.
        • Anastasakis A.
        • Borjesson M.
        • Bjornstad H.H.
        • Carre F.
        • Deligiannis A.
        • Dugmore D.
        • Fagard R.
        • Hoogsteen J.
        • Mellwig K.P.
        • Panhuyzen-Goedkoop N.
        • Solberg E.
        • Vanhees L.
        • Drezner J.
        • Estes 3rd, N.A.
        • Iliceto S.
        • Maron B.J.
        • Peidro R.
        • Schwartz P.J.
        • Stein R.
        • Thiene G.
        • Zeppilli P.
        • McKenna W.J.
        • Section of Sports Cardiology, European Association of Cardiovascular Prevention and Rehabilitation
        Recommendations for interpretation of 12-lead electrocardiogram in the athlete.
        Eur Heart J. 2010; 31: 243-259
        • Sokolow M.
        • Lyon T.P.
        The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads.
        Am Heart J. 1949; 37: 161-186
        • Molloy T.J.
        • Okin P.M.
        • Devereux R.B.
        • Kligfield P.
        Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.
        J Am Coll Cardiol. 1992; 20: 1180-1186
        • Lang R.M.
        • Bierig M.
        • Devereux R.B.
        • Flachskampf F.A.
        • Foster E.
        • Pellikka P.A.
        • Picard M.H.
        • Roman M.J.
        • Seward J.
        • Shanewise J.S.
        • Solomon S.D.
        • Spencer K.T.
        • Sutton M.S.
        • Stewart W.J.
        • Chamber Quantification Writing Group, American Society of Echocardiography's Guidelines and Standards Committee, European Association of Echocardiography
        Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
        J Am Soc Echocardiogr. 2005; 18: 1440-1463
        • Ward R.P.
        • Weinert L.
        • Spencer K.T.
        • Furlong K.T.
        • Bednarz J.
        • DeCara J.
        • Lang R.M.
        Quantitative diagnosis of apical cardiomyopathy using contrast echocardiography.
        J Am Soc Echocardiogr. 2002; 15: 316-322
        • Eriksson M.J.
        • Sonnenberg B.
        • Woo A.
        • Rakowski P.
        • Parker T.G.
        • Wigle E.D.
        • Rakowski H.
        Long-term outcome in patients with apical hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2002; 39: 638-645
        • Shah J.S.
        • Esteban M.T.
        • Thaman R.
        • Sharma R.
        • Mist B.
        • Pantazis A.
        • Ward D.
        • Kohli S.K.
        • Page S.P.
        • Demetrescu C.
        • Sevdalis E.
        • Keren A.
        • Pellerin D.
        • McKenna W.J.
        • Elliott P.M.
        Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.
        Heart. 2008; 94: 1288-1294
        • Yu C.M.
        • Sanderson J.E.
        • Marwick T.H.
        • Oh J.K.
        Tissue Doppler imaging a new prognosticator for cardiovascular diseases.
        J Am Coll Cardiol. 2007; 49: 1903-1914
        • Marwick T.H.
        • Nakatani S.
        • Haluska B.
        • Thomas J.D.
        • Lever H.M.
        Provocation of latent left ventricular outflow tract gradients with amyl nitrite and exercise in hypertrophic cardiomyopathy.
        Am J Cardiol. 1995; 75: 805-809
        • Papadakis M.
        • Carre F.
        • Kervio G.
        • Rawlins J.
        • Panoulas V.F.
        • Chandra N.
        • Basavarajaiah S.
        • Carby L.
        • Fonseca T.
        • Sharma S.
        The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin.
        Eur Heart J. 2011; 32: 2304-2313
        • Lewis B.S.
        • Agathangelou N.E.
        • Flax H.
        • Taams M.A.
        • Barlow J.B.
        Hypertrophic cardiomyopathy in South African blacks.
        S Afr Med J. 1983; 63: 266-270
        • Heradien M.
        • Goosen A.
        • Moolman-Smook J.C.
        • Brink P.A.
        Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting.
        Cardiovasc J Afr. 2007; 18: 312-315
        • Okin P.M.
        • Wright J.T.
        • Nieminen M.S.
        • Jern S.
        • Taylor A.L.
        • Phillips R.
        • Papademetriou V.
        • Clark L.T.
        • Ofili E.O.
        • Randall O.S.
        • Oikarinen L.
        • Viitasalo M.
        • Toivonen L.
        • Julius S.
        • Dahlof B.
        • Devereux R.B.
        Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan intervention for endpoint.
        Am J Hypertens. 2002; 15: 663-671
        • Drazner M.H.
        • Dries D.L.
        • Peshock R.M.
        • Cooper R.S.
        • Klassen C.
        • Kazi F.
        • Willett D.
        • Victor R.G.
        Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study.
        Hypertension. 2005; 46: 124-129
        • Aslam F.
        • Haque A.
        • Foody J.
        • Shirani J.
        The frequency and functional impact of overlapping hypertension on hypertrophic cardiomyopathy: a single-center experience.
        J Clin Hypertens (greenwich). 2010; 12: 240-245
        • Kramer H.
        • Han C.
        • Post W.
        • Goff D.
        • Diez-Roux A.
        • Cooper R.
        • Jinagouda S.
        • Shea S.
        Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA).
        Am J Hypertens. 2004; 17: 963-970